vs

Side-by-side financial comparison of ALKAMI TECHNOLOGY, INC. (ALKT) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $126.1M, roughly 1.6× ALKAMI TECHNOLOGY, INC.). REPLIGEN CORP runs the higher net margin — 6.7% vs -7.9%, a 14.6% gap on every dollar of revenue. On growth, ALKAMI TECHNOLOGY, INC. posted the faster year-over-year revenue change (28.9% vs 13.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $-7.4M). Over the past eight quarters, ALKAMI TECHNOLOGY, INC.'s revenue compounded faster (23.9% CAGR vs 14.4%).

Alkami Technology, Inc. delivers cloud-native digital banking platforms and supporting solutions for US financial institutions. Its offerings include online and mobile banking interfaces, payment processing tools, data analytics modules, and customer engagement functionalities, primarily serving community banks and credit unions to enhance their customers' digital banking experiences.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

ALKT vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.6× larger
RGEN
$197.9M
$126.1M
ALKT
Growing faster (revenue YoY)
ALKT
ALKT
+15.3% gap
ALKT
28.9%
13.6%
RGEN
Higher net margin
RGEN
RGEN
14.6% more per $
RGEN
6.7%
-7.9%
ALKT
More free cash flow
RGEN
RGEN
$24.9M more FCF
RGEN
$17.6M
$-7.4M
ALKT
Faster 2-yr revenue CAGR
ALKT
ALKT
Annualised
ALKT
23.9%
14.4%
RGEN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALKT
ALKT
RGEN
RGEN
Revenue
$126.1M
$197.9M
Net Profit
$-10.0M
$13.3M
Gross Margin
58.6%
52.5%
Operating Margin
36.9%
9.0%
Net Margin
-7.9%
6.7%
Revenue YoY
28.9%
13.6%
Net Profit YoY
-27.5%
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALKT
ALKT
RGEN
RGEN
Q1 26
$126.1M
Q4 25
$120.8M
$197.9M
Q3 25
$113.0M
$188.8M
Q2 25
$112.1M
$182.4M
Q1 25
$97.8M
$169.2M
Q4 24
$89.7M
$174.1M
Q3 24
$85.9M
$154.9M
Q2 24
$82.2M
$154.1M
Net Profit
ALKT
ALKT
RGEN
RGEN
Q1 26
$-10.0M
Q4 25
$13.3M
Q3 25
$-14.8M
$14.9M
Q2 25
$-13.6M
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-9.4M
$-654.0K
Q2 24
$-12.3M
$3.3M
Gross Margin
ALKT
ALKT
RGEN
RGEN
Q1 26
58.6%
Q4 25
57.2%
52.5%
Q3 25
56.8%
53.2%
Q2 25
58.6%
50.0%
Q1 25
59.0%
53.6%
Q4 24
59.3%
26.1%
Q3 24
58.9%
50.0%
Q2 24
59.4%
49.8%
Operating Margin
ALKT
ALKT
RGEN
RGEN
Q1 26
36.9%
Q4 25
-7.9%
9.0%
Q3 25
-11.4%
8.9%
Q2 25
-14.2%
7.6%
Q1 25
-15.7%
3.9%
Q4 24
-9.6%
-17.7%
Q3 24
-12.1%
-5.1%
Q2 24
-16.1%
1.0%
Net Margin
ALKT
ALKT
RGEN
RGEN
Q1 26
-7.9%
Q4 25
6.7%
Q3 25
-13.1%
7.9%
Q2 25
-12.1%
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-11.0%
-0.4%
Q2 24
-15.0%
2.2%
EPS (diluted)
ALKT
ALKT
RGEN
RGEN
Q1 26
Q4 25
$-0.11
$0.24
Q3 25
$-0.14
$0.26
Q2 25
$-0.13
$0.26
Q1 25
$-0.08
$0.10
Q4 24
$-0.07
$-0.55
Q3 24
$-0.09
$-0.01
Q2 24
$-0.13
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALKT
ALKT
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$40.4M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$370.7M
$2.1B
Total Assets
$829.3M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALKT
ALKT
RGEN
RGEN
Q1 26
$40.4M
Q4 25
$63.5M
$767.6M
Q3 25
$57.3M
$748.7M
Q2 25
$52.4M
$708.9M
Q1 25
$61.7M
$697.2M
Q4 24
$94.4M
$757.4M
Q3 24
$81.0M
$784.0M
Q2 24
$61.4M
$809.1M
Total Debt
ALKT
ALKT
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
ALKT
ALKT
RGEN
RGEN
Q1 26
$370.7M
Q4 25
$362.0M
$2.1B
Q3 25
$350.1M
$2.1B
Q2 25
$344.0M
$2.1B
Q1 25
$334.0M
$2.0B
Q4 24
$357.0M
$2.0B
Q3 24
$338.5M
$2.0B
Q2 24
$327.2M
$2.0B
Total Assets
ALKT
ALKT
RGEN
RGEN
Q1 26
$829.3M
Q4 25
$847.2M
$2.9B
Q3 25
$835.2M
$2.9B
Q2 25
$840.4M
$2.9B
Q1 25
$837.2M
$2.9B
Q4 24
$437.3M
$2.8B
Q3 24
$422.2M
$2.8B
Q2 24
$403.9M
$2.9B
Debt / Equity
ALKT
ALKT
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALKT
ALKT
RGEN
RGEN
Operating Cash FlowLast quarter
$-4.8M
$25.7M
Free Cash FlowOCF − Capex
$-7.4M
$17.6M
FCF MarginFCF / Revenue
-5.8%
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALKT
ALKT
RGEN
RGEN
Q1 26
$-4.8M
Q4 25
$16.6M
$25.7M
Q3 25
$30.8M
$48.1M
Q2 25
$1.2M
$28.6M
Q1 25
$-5.7M
$15.0M
Q4 24
$6.1M
$39.2M
Q3 24
$11.0M
$49.3M
Q2 24
$548.0K
$42.2M
Free Cash Flow
ALKT
ALKT
RGEN
RGEN
Q1 26
$-7.4M
Q4 25
$16.2M
$17.6M
Q3 25
$30.5M
$43.4M
Q2 25
$760.0K
$21.5M
Q1 25
$-6.1M
$11.4M
Q4 24
$6.0M
$33.6M
Q3 24
$10.7M
$42.3M
Q2 24
$123.0K
$37.4M
FCF Margin
ALKT
ALKT
RGEN
RGEN
Q1 26
-5.8%
Q4 25
13.4%
8.9%
Q3 25
27.0%
23.0%
Q2 25
0.7%
11.8%
Q1 25
-6.3%
6.8%
Q4 24
6.6%
19.3%
Q3 24
12.4%
27.3%
Q2 24
0.1%
24.3%
Capex Intensity
ALKT
ALKT
RGEN
RGEN
Q1 26
Q4 25
0.3%
4.1%
Q3 25
0.2%
2.5%
Q2 25
0.4%
3.9%
Q1 25
0.5%
2.1%
Q4 24
0.2%
3.2%
Q3 24
0.4%
4.5%
Q2 24
0.5%
3.1%
Cash Conversion
ALKT
ALKT
RGEN
RGEN
Q1 26
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons